Načítá se...
JAK/STAT signaling in hepatocellular carcinoma
Liver cancer is the second most lethal cancer in the world with limited treatment options. Hepatocellular carcinoma (HCC), which accounts for more than 80% of all liver cancers, has had increasing global incidence over the past few years. There is an urgent need for novel and better therapeutic inte...
Uloženo v:
| Vydáno v: | Hepat Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7137178/ https://ncbi.nlm.nih.gov/pubmed/32273976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2020-0001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|